D-0662-2026 Class II Ongoing

Recalled by ONESOURCE SPECIALTY PHARMA LIMITED — Bengaluru, N/A

FDA drug recall D-0662-2026 was initiated by ONESOURCE SPECIALTY PHARMA LIMITED on Jun 7, 2026 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is ongoing. Affected quantity: 4284 vials.

Recall details

Product Type
Drugs
Report Date
Jul 15, 2026
Initiation Date
Jun 7, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4284 vials

Product description

Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31

Reason for recall

Failed Impurities/Degradation Specifications

Distribution pattern

Nationwide within the United States

Code information

Lot #: 7000612A, Exp. Date 1/2028

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0662-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0662-2026. Report a data issue: hello@regdatalab.com.